MedImmune is the global biologics research and development arm of AstraZeneca, a global, innovation-driven biopharmaceutical business that focuses on the discovery, development and commercialization of small molecule and biologic prescription medicines. MedImmune is pioneering innovative research and exploring novel pathways across Oncology, Respiratory, Cardiovascular & Metabolic Diseases, and Infection and Vaccines.
Organovo develops dynamic, multicellular, 3D bioprinted human tissues that closely model native biology. With the NovoGen Brioprinter® Platform, the Company designs tissues for use in applications spanning preclinical safety testing, disease modeling, and therapeutics. ExVive™ Human Liver and Kidney Tissues are commercially available through their NovoView™ Preclinical Services and enable mechanistic insights into phenotypes that progress over time and require multiple cell types in a specific spatial organization, reflecting the true complexity of human biology. www.organovo.com
Antaros Medical is pioneering imaging methodologies to design and deliver clinical imaging studies for improved, evidence-based decision making in drug development. The company is specialized in cardio-metabolic diseases (incl NAFLD/NASH) and oncology. The company has today a global network of collaboration partners and customers, including both big and small drug developing companies, and is a partner in several European collaboration initiatives eg Innovative Medicines Initiative (IMI).
Cisbio Bioassays focuses on improving health care by offering the highest quality drug discovery solutions. Using our Homogeneous Time Resolved Fluorescence (HTRF®) technology, researchers can easily and accurately accelerate discoveries involving protein interactions as well as other biological applications. Cisbio continuously develops new products and applications to meet researcher needs. Our metabolism portfolio includes over 50 assays for the investigation of the molecular mechanisms involved in the development and progression of NASH, NAFLD and Fibrosis.